Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enovis (ENOV) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Enovis (ENOV) over the last 17 years, with Q4 2025 value amounting to $33.6 million.

  • Enovis' Cash & Equivalents fell 510.37% to $33.6 million in Q4 2025 from the same period last year, while for Oct 2025 it was $33.6 million, marking a year-over-year decrease of 510.37%. This contributed to the annual value of $48.2 million for FY2024, which is 3309.11% up from last year.
  • According to the latest figures from Q4 2025, Enovis' Cash & Equivalents is $33.6 million, which was down 510.37% from $44.1 million recorded in Q3 2025.
  • Enovis' 5-year Cash & Equivalents high stood at $763.7 million for Q2 2021, and its period low was $21.9 million during Q1 2023.
  • Over the past 5 years, Enovis' median Cash & Equivalents value was $44.1 million (recorded in 2025), while the average stood at $154.9 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first soared by 60079.94% in 2021, then tumbled by 9668.94% in 2023.
  • Enovis' Cash & Equivalents (Quarter) stood at $680.3 million in 2021, then plummeted by 96.43% to $24.3 million in 2022, then surged by 48.96% to $36.2 million in 2023, then surged by 33.09% to $48.2 million in 2024, then crashed by 30.21% to $33.6 million in 2025.
  • Its Cash & Equivalents was $33.6 million in Q4 2025, compared to $44.1 million in Q3 2025 and $38.5 million in Q2 2025.